Browse by Author "Giraldo, Pilar"

Now showing items 1-2 of 2

Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-alpha. Results of the CML89 trial of the Spanish Collaborative Group on interferon-alpha2a and CML

1999- Steegmann, Juan Luís; Odriozola, Jesús; Rodriguez Salvanés, Francisco; Giraldo, Pilar; García Laraña, José; [et al.]
Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project

2018-02- Giraldo, Pilar; Andrade-Campos, Marcio; Alfonso, Pilar; Irun, Pilar; Atutxa, Koldo; [et al.]